By Ron Lanton III, Esq. | Lanton, Lanton & Sosa Law PLLC
Not every company needs a lobbyist. However, businesses facing legislation that could affect revenue, operating costs, licensing, or market access should consider whether government affairs representation belongs in their 2027 plans.
The decision should begin with a business question: What could the proposed policy cost the company, and is there an opportunity to influence how it is developed?
For healthcare organizations, pharmaceutical companies, and other regulated businesses, legislative decisions can have substantial financial consequences. Changes to reimbursement, professional licensing, pharmacy regulation, or business operations can affect existing contracts, expansion plans, and long-term investments.
Companies should understand those potential consequences before deciding whether to commit resources to government affairs.
When Does Representation Make Business Sense?
A company should consider government affairs representation when proposed legislation or regulation could materially affect its operations or financial performance.
For example, a pharmacy facing changes to reimbursement requirements may need to explain how those changes would affect its ability to serve patients. A biotechnology company considering expansion may encounter legislative or regulatory requirements that affect its investment decisions. A healthcare organization may need to address proposed restrictions on its existing operations.
In each situation, management should determine whether the company's interests are already being represented through a trade association or whether direct engagement is necessary.
The cost of representation should also be weighed against the potential financial consequences of the policy. A company facing a significant reimbursement reduction or regulatory expense may have good reason to participate directly in the legislative process. A business facing a relatively minor change may find that routine monitoring is sufficient.
Timing matters. Companies that wait until legislation is approaching a final vote may have fewer opportunities to explain their concerns, suggest amendments, or provide lawmakers with information about how a proposal would work in practice.
Early engagement allows companies to participate while legislative language is still being considered. It also provides an opportunity to support legislation that would benefit their operations or address longstanding industry problems.
What Should Management Do Before 2027?
Executives should identify the legislative and regulatory issues most likely to affect their businesses in the coming year. That includes reviewing proposals from previous sessions, identifying relevant committees and government agencies, and assessing whether existing industry associations are addressing those issues.
Companies considering outside representation should establish specific objectives before retaining a government affairs professional. Those objectives might include supporting legislation, proposing amendments, addressing regulatory concerns, or explaining the financial consequences of a proposed policy.
Management should also understand the scope of the engagement, expected costs, and how progress will be evaluated. Government affairs representation provides access to the legislative process and an opportunity to advocate for business interests. It does not guarantee a particular outcome.
For companies operating in multiple states, the planning process may require additional attention. Similar proposals can move through different legislatures on different schedules, and a policy that affects operations in one state may later be considered elsewhere.
Government affairs should be evaluated like any other business expense. The potential impact of legislation, the opportunity to participate in its development, and the cost of representation should determine whether an investment is justified.
For companies facing significant policy decisions in 2027, that evaluation should begin before the legislative sessions are underway.
This article is for general informational purposes and does not constitute legal advice.